Probiotic Medilac-S® for the induction of clinical remission in a Chinese population with ulcerative colitis: A systematic review and meta-analysis

Figure 11 Funnel plot showing the relationship between the relative risk and its standard error for each of 11 studies used in a fixed effects meta-analysis with a moderator for concomitant drug therapy evaluating the effect of Medilac-S^® in combination with conventional drug therapy on number of reported clinical symptoms for (A) abdominal pain and (B) tenesmus.